Nephrol Dial Transplant (2001) 16: 1475-1478
© 2001 European Renal Association-European Dialysis and Transplant Association
Case Report
Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations
1 Chair of Nephrology and Graduate School of Nephrology, University of Milan, 2 Division of Nephrology, S. Carlo Borromeo Hospital, 3 Division of Nephrology, Dialysis and Hypertension, S. Raffaele Hospital, 4 Department of Pathology, S. Raffaele Hospital, Milan, and 5 Division of Nephrology, A. Manzoni Hospital, Lecco, Italy
Keywords: AA amyloidosis; autoimmune manifestations; Castleman's disease (hyalinevascular type); nephrotic syndrome; uveitis; venous thrombosis
| Introduction |
|---|
Castleman's disease (also called giant lymph-node hyperplasia or angiofollicular lymph-node hyperplasia) is a highly heterogeneous clinico-pathological entity belonging to the lympho-proliferative disorders. Originally described in 1956 by Castleman and co-workers [1] as a large, benign, unique asymptomatic mass of mediastinal lymph nodes, it was shown in subsequent reports to include extra-mediastinal and multicentric forms [2].
Two histological patterns of lymph nodes were described: the hyalinevascular and plasma-cell types. The former is more common (8090%), and is characterized by the proliferation of capillary vessels in germinal centres of lymphatic folliculi, which assume a hyaline aspect. It is classically reported to have mono-localization, often mediastinal, and a benign course after removal of the mass. The plasma-cell variant is less frequent (1020%) and presents hyperplastic follicles interspersed by sheets of plasma cells. It is often multi-centric and usually associated with systemic manifestations of inflammatory disease. The prognosis is worse,
| Case |
|---|
| Discussion |
|---|
| Acknowledgments |
|---|
| Notes |
|---|
| References |
|---|
This article has been cited by other articles:
![]() |
T. H. Lee, W. Kim, Y. B. Jeong, K. Y. Jang, and S. K. Park Haematuria and hydronephrosis caused by Castleman's disease NDT Plus, December 1, 2009; 2(6): 502 - 503. [Full Text] [PDF] |
||||
![]() |
H.J. Lachmann, J.A. Gilbertson, J.D. Gillmore, P.N. Hawkins, and M.B. Pepys Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease QJM, April 1, 2002; 95(4): 211 - 218. [Abstract] [Full Text] [PDF] |
||||

